Administration of brincidofovir and convalescent plasma in a patient with Ebola virus disease
DF Florescu, AC Kalil, AL Hewlett… - Clinical Infectious …, 2015 - academic.oup.com
Clinical Infectious Diseases, 2015•academic.oup.com
Abstract From 2014 to May 2015,> 26 000 Ebola virus disease (EVD) cases were reported
from West Africa. We present a patient with EVD who received brincidofovir and
convalescent plasma. The relative contributions of supportive care, investigational therapies,
and patient's immune-response on survival could not be determined. Randomized trials are
needed.
from West Africa. We present a patient with EVD who received brincidofovir and
convalescent plasma. The relative contributions of supportive care, investigational therapies,
and patient's immune-response on survival could not be determined. Randomized trials are
needed.
Abstract
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.
Oxford University Press